below, was diluted in normal saline (after adjusting the pH to 2.7) decrease in serum calcium concentration follows glucagon admin-so [hat [he total volume given was 0.01 ml/g of body weight. istration in doses of 1 to 10 mg/kg. The effects of maturation and clystalline insulin similarly diluted was given as noted 15
On thi s phenomenon were assessed the before glucagon. Controls received equivalent volumes of normal response of newborn and adult rats doses glucagon saline. Blood samples were secured in group I by decapitation. In with and without prior insulin administration. After injection of 1 groups 11 and 111, venous blood was drawn under chloral hydrate C(g/g of glucagon* the decrease in serum cal ci um at anesthesia; this agent was also used for pancreatectomy. Calcium 60 min was si @fi cnnt in the newborn rats mg/dl; < was measured by the method of Bett and Fraser (I) as adapted for 0.001) and not si@ficmt in the adults (-OSo7 mg/dl; > the Oxford titrator. Results are given as mean * S.E., and differ-
0.1).
ences between group means were assigned significance by Stu-I n pancreatomized adults, the decrease in serum calcium after dent's test.
the same dose of glucagon became significant (-1.23 mg/dl; P 5 0.01). This hypocalcemic effect was prevented in the pancreatectomized adult rat if insulin in a dose of 0.01 p/g was given 15 min RESULTS before glucagon. I n the newborn rats, the same dose of insulin Figure I and Table 1 show the effects of glucagon in group 1. decreased the hypocalcemic effect, but the change was still sig-At 60 min, a significant decrease in calcium followed administranificant (-0.74 mg/dl; P < 0.01).
tion of 0.1 pg/g. The effect of 1.0 pg/g was greater; no further Glucagon decreased serum calcium at one hr in newborn rats change followed 10 pg/g. Because the maximal effect appeared 60 but not in adults. After pancreatectomy, the adult response to glucagon was significant and similar to that of the newborn. Insulin cancelled this effect of glucagon in the pancreatectomized adults is sluggish in the neonatal period, glucagon may have a clinically significant effect on serum calcium concentration at this time.
-
The frequency and severity of hypocalcemia within the first 48 u hr of life are increased by prematurity, perinatal trauma, hypoxia, \ and maternal diabetes (3, 10) . Functional hypoparathyroidism has been demonstrated in some of these situations (3, 10 Three groups of albino rats (strain TAC: SD/N f BR) were newborn rats. The effects of three different doses are compared at 60 min. used: I. newborn (less than 48 hr old), average wt. 7 f 0.1 g. 11. The time course is shown for the highest dose studied (10 gg/g). NS, not significant. min after I pg/g, this dose and interval were used to compare responses in the three groups studied.
In Group I1 (intact adults), neither I pg/g IP nor 0.5 pg/g IV affected semm calcium at 60 rnin ( Fig. 2 ; Table I ). After pancreatectomy (group 111). a glucagon dose of 0.5 pg/g IV led to a decrease of 1.23 mg/dl at 60 min ( Fig. 2 ; Table I ).
In group I, administration of insulin 15 rnin before glucagon reduced the degree of hypocalcemia at 60 min from -1.81 * 0.22 to -0.74 f . I0 mg/dl (P < 0.01). Pancreatectomized adults (group 111) showed no change in calcium when glucagon was preceded by insulin.
DISCUSSION
The demonstration that newborn rats are more susceptible than adults to the hypocalcemic effect of glucagon is not surprising in view of the precarious state of calcium homeostasis in the neonatal period. In this case, pancreatic rather than parathyroid function appears to be a major factor. Insulin increased calcium concentration in the newborn rats. Pancreatectomized adults with intact parathyroids showed postglucagon hypocalcemia, and exogenous insulin mitigated hypocalcemia in newborns and abolished it in adults. This finding contrasts with results reported by Williams et al. (I I) who found no interaction between 25 munits of insulin and 200 pg of glucagon. At these doses. the molar ratio was 0.0029 (MW of glucagon, 3485); we used 10 munits of insulin per 1.0 pg of glucagon, giving an insulin/glucagon molar ratio of 0.23 (IU insulin = 40 pg; MW = 6000). Previous studies have shown that the hypocalcemic effect of glucagon was not dependent on the presence of the thyroid, parathyroid, or kidneys (6. 8. 1 I). Hyperglycemia induced by glucose infusion did not affect serum calcium concentration (I I). I n vitro, bone calcium release in response to parathyroid hormone or to cyclic adenosine 3':s'-monophosphate was inhibited by glucagon as it was by calcitonin and cortisol (4, . --9) . These findings suggest that glucagon affects the equilibrium between bone mineral and interstitial fluid by a mechanism presently obscure. Whether this action, alone o; in conjunction with other factors, is clinically important cannot be assessed on the basis of currently available data. Inhibition by insulin suggests that the mechanism may be related to bone cell carbohydrate metabolism.
